Stephan Holzschuh

Stephan Holzschuh is currently engaged in an MSAT Drug Product assignment at Viralgen Vector Core and has held several roles at Bayer, where they focused on parenteral drug delivery and external drug product development. Previously, they directed pharmaceutical formulation and process development, emphasizing RNA, peptide, and oligonucleotide projects. Stephan completed a Ph.D. in Pharmaceutical Technology, along with a degree in Pharmacy and a Diploma in Pharmazie, all from Friedrich-Schiller-Universität Jena. Their extensive background includes leadership in CMC project management and cross-functional team collaboration.